811 Usefullness of the Prism III Score to Predict Outcome in Critically ill Children with VAP
Background and Aims Ventilator-associated pneumonia (VAP) is associated with increased length of stay and adverse outcomes in PICU patients. In a retrospective study, we examined if PRISM III score at admission or at the day of VAP development could better predict the outcome in patients with VAP. M...
Gespeichert in:
| Veröffentlicht in: | Archives of disease in childhood 2012-10, Vol.97 (Suppl 2), p.A233-A233 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | A233 |
|---|---|
| container_issue | Suppl 2 |
| container_start_page | A233 |
| container_title | Archives of disease in childhood |
| container_volume | 97 |
| creator | Stabouli, S Volakli, E Violaki, A Tsolaki, A Dimitriadou, M Skoumis, K Sdougka, M |
| description | Background and Aims Ventilator-associated pneumonia (VAP) is associated with increased length of stay and adverse outcomes in PICU patients. In a retrospective study, we examined if PRISM III score at admission or at the day of VAP development could better predict the outcome in patients with VAP. Methods The medical records of PICU patients admitted to a 8-Bed PICU of a tertiary-care hospital from January–December 2011 were reviewed. Clinical data, PRISM III score at admission or at the day of VAP development were recorded. VAP was diagnosed according to CDC criteria. Results 27 patients, mean age 4.40±4.23 years, 59.3% boys, developed VAP. 4 patients presented 2 VAP episodes. Mean PRISM III score at admission was 10.19±7.65, at the day of first VAP episode 7.31±6.94, and at the day of 2nd VAP episode 4.75±3.60. The receiver operator characteristic curve (ROC) analysis showed that PRISM III at admission could better predict mortality in PICU patients with VAP than PRISM III at the day of VAP episode. (Figure 1). Abstract 811 Figure 1 The area under the curve was found 0.85 (asymptotic 95%CI 0.59 to 1, P |
| doi_str_mv | 10.1136/archdischild-2012-302724.0811 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1828858739</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4214746631</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2841-5e8c8e7958e06bba96c649b598803ea64fa2d2b7c5d3ce0afdfe2b3bc8a531c63</originalsourceid><addsrcrecordid>eNqVkF1LwzAUhoMoOKf_ISBeduajadMLL0bRORnbwG13EtL0lGV260w6dP_ejIp469WBw_OejwehO0oGlPLkXjuzLq03a1uXESOURZywlMUDIik9Qz0aJzL04_gc9QghPMqklJfoyvsNCbSUvIfeAoqXHqpDXe_Ae9xUuF0Dnjvrt3g8HuNX0zjAbRNaUFrT4tmhNc0WsN3h3NnWGl3XR2zrGuenSxzs8Kdt13g1nF-ji0rXHm5-ah8tnx4X-XM0mY3G-XASFUzGNBIgjYQ0ExJIUhQ6S0wSZ4UI9xIOOokrzUpWpEaU3ADRVVkBK3hhpBacmoT30W03d--ajwP4Vm2ag9uFlYrK8KiQKc8C9dBRxjXeO6jU3tmtdkdFiToZVX-NqpNR1RlVJ6MhH3V561v4-g1r966SlKdCTVe5yl8WIh1NmRKBlx1fbDf_XPUNju6N8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1828858739</pqid></control><display><type>article</type><title>811 Usefullness of the Prism III Score to Predict Outcome in Critically ill Children with VAP</title><source>BMJ Journals - NESLi2</source><creator>Stabouli, S ; Volakli, E ; Violaki, A ; Tsolaki, A ; Dimitriadou, M ; Skoumis, K ; Sdougka, M</creator><creatorcontrib>Stabouli, S ; Volakli, E ; Violaki, A ; Tsolaki, A ; Dimitriadou, M ; Skoumis, K ; Sdougka, M</creatorcontrib><description>Background and Aims Ventilator-associated pneumonia (VAP) is associated with increased length of stay and adverse outcomes in PICU patients. In a retrospective study, we examined if PRISM III score at admission or at the day of VAP development could better predict the outcome in patients with VAP. Methods The medical records of PICU patients admitted to a 8-Bed PICU of a tertiary-care hospital from January–December 2011 were reviewed. Clinical data, PRISM III score at admission or at the day of VAP development were recorded. VAP was diagnosed according to CDC criteria. Results 27 patients, mean age 4.40±4.23 years, 59.3% boys, developed VAP. 4 patients presented 2 VAP episodes. Mean PRISM III score at admission was 10.19±7.65, at the day of first VAP episode 7.31±6.94, and at the day of 2nd VAP episode 4.75±3.60. The receiver operator characteristic curve (ROC) analysis showed that PRISM III at admission could better predict mortality in PICU patients with VAP than PRISM III at the day of VAP episode. (Figure 1). Abstract 811 Figure 1 The area under the curve was found 0.85 (asymptotic 95%CI 0.59 to 1, P<0.01) for PRISM III at admission and 0.72 (95%CI 0.48 to 0.95, P=0,081) for PRISM III at VAP episode. Conclusions PRISM III at admission could better predict mortality in PICU patients with VAP than PRISM III at the day of VAP episode suggesting that VAP may not independently affect mortality.</description><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/archdischild-2012-302724.0811</identifier><identifier>CODEN: ADCHAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</publisher><subject>Attrition (Research Studies) ; Mortality ; Patients</subject><ispartof>Archives of disease in childhood, 2012-10, Vol.97 (Suppl 2), p.A233-A233</ispartof><rights>2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><rights>Copyright: 2012 (c) 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b2841-5e8c8e7958e06bba96c649b598803ea64fa2d2b7c5d3ce0afdfe2b3bc8a531c63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://adc.bmj.com/content/97/Suppl_2/A233.1.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://adc.bmj.com/content/97/Suppl_2/A233.1.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,778,782,3185,23558,27911,27912,77355,77386</link.rule.ids></links><search><creatorcontrib>Stabouli, S</creatorcontrib><creatorcontrib>Volakli, E</creatorcontrib><creatorcontrib>Violaki, A</creatorcontrib><creatorcontrib>Tsolaki, A</creatorcontrib><creatorcontrib>Dimitriadou, M</creatorcontrib><creatorcontrib>Skoumis, K</creatorcontrib><creatorcontrib>Sdougka, M</creatorcontrib><title>811 Usefullness of the Prism III Score to Predict Outcome in Critically ill Children with VAP</title><title>Archives of disease in childhood</title><addtitle>Arch Dis Child</addtitle><description>Background and Aims Ventilator-associated pneumonia (VAP) is associated with increased length of stay and adverse outcomes in PICU patients. In a retrospective study, we examined if PRISM III score at admission or at the day of VAP development could better predict the outcome in patients with VAP. Methods The medical records of PICU patients admitted to a 8-Bed PICU of a tertiary-care hospital from January–December 2011 were reviewed. Clinical data, PRISM III score at admission or at the day of VAP development were recorded. VAP was diagnosed according to CDC criteria. Results 27 patients, mean age 4.40±4.23 years, 59.3% boys, developed VAP. 4 patients presented 2 VAP episodes. Mean PRISM III score at admission was 10.19±7.65, at the day of first VAP episode 7.31±6.94, and at the day of 2nd VAP episode 4.75±3.60. The receiver operator characteristic curve (ROC) analysis showed that PRISM III at admission could better predict mortality in PICU patients with VAP than PRISM III at the day of VAP episode. (Figure 1). Abstract 811 Figure 1 The area under the curve was found 0.85 (asymptotic 95%CI 0.59 to 1, P<0.01) for PRISM III at admission and 0.72 (95%CI 0.48 to 0.95, P=0,081) for PRISM III at VAP episode. Conclusions PRISM III at admission could better predict mortality in PICU patients with VAP than PRISM III at the day of VAP episode suggesting that VAP may not independently affect mortality.</description><subject>Attrition (Research Studies)</subject><subject>Mortality</subject><subject>Patients</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkF1LwzAUhoMoOKf_ISBeduajadMLL0bRORnbwG13EtL0lGV260w6dP_ejIp469WBw_OejwehO0oGlPLkXjuzLq03a1uXESOURZywlMUDIik9Qz0aJzL04_gc9QghPMqklJfoyvsNCbSUvIfeAoqXHqpDXe_Ae9xUuF0Dnjvrt3g8HuNX0zjAbRNaUFrT4tmhNc0WsN3h3NnWGl3XR2zrGuenSxzs8Kdt13g1nF-ji0rXHm5-ah8tnx4X-XM0mY3G-XASFUzGNBIgjYQ0ExJIUhQ6S0wSZ4UI9xIOOokrzUpWpEaU3ADRVVkBK3hhpBacmoT30W03d--ajwP4Vm2ag9uFlYrK8KiQKc8C9dBRxjXeO6jU3tmtdkdFiToZVX-NqpNR1RlVJ6MhH3V561v4-g1r966SlKdCTVe5yl8WIh1NmRKBlx1fbDf_XPUNju6N8A</recordid><startdate>201210</startdate><enddate>201210</enddate><creator>Stabouli, S</creator><creator>Volakli, E</creator><creator>Violaki, A</creator><creator>Tsolaki, A</creator><creator>Dimitriadou, M</creator><creator>Skoumis, K</creator><creator>Sdougka, M</creator><general>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88B</scope><scope>88E</scope><scope>88I</scope><scope>8A4</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>CJNVE</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0P</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>201210</creationdate><title>811 Usefullness of the Prism III Score to Predict Outcome in Critically ill Children with VAP</title><author>Stabouli, S ; Volakli, E ; Violaki, A ; Tsolaki, A ; Dimitriadou, M ; Skoumis, K ; Sdougka, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2841-5e8c8e7958e06bba96c649b598803ea64fa2d2b7c5d3ce0afdfe2b3bc8a531c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Attrition (Research Studies)</topic><topic>Mortality</topic><topic>Patients</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stabouli, S</creatorcontrib><creatorcontrib>Volakli, E</creatorcontrib><creatorcontrib>Violaki, A</creatorcontrib><creatorcontrib>Tsolaki, A</creatorcontrib><creatorcontrib>Dimitriadou, M</creatorcontrib><creatorcontrib>Skoumis, K</creatorcontrib><creatorcontrib>Sdougka, M</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Education Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Education Periodicals</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Education Collection</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Education Database</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stabouli, S</au><au>Volakli, E</au><au>Violaki, A</au><au>Tsolaki, A</au><au>Dimitriadou, M</au><au>Skoumis, K</au><au>Sdougka, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>811 Usefullness of the Prism III Score to Predict Outcome in Critically ill Children with VAP</atitle><jtitle>Archives of disease in childhood</jtitle><addtitle>Arch Dis Child</addtitle><date>2012-10</date><risdate>2012</risdate><volume>97</volume><issue>Suppl 2</issue><spage>A233</spage><epage>A233</epage><pages>A233-A233</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><coden>ADCHAK</coden><abstract>Background and Aims Ventilator-associated pneumonia (VAP) is associated with increased length of stay and adverse outcomes in PICU patients. In a retrospective study, we examined if PRISM III score at admission or at the day of VAP development could better predict the outcome in patients with VAP. Methods The medical records of PICU patients admitted to a 8-Bed PICU of a tertiary-care hospital from January–December 2011 were reviewed. Clinical data, PRISM III score at admission or at the day of VAP development were recorded. VAP was diagnosed according to CDC criteria. Results 27 patients, mean age 4.40±4.23 years, 59.3% boys, developed VAP. 4 patients presented 2 VAP episodes. Mean PRISM III score at admission was 10.19±7.65, at the day of first VAP episode 7.31±6.94, and at the day of 2nd VAP episode 4.75±3.60. The receiver operator characteristic curve (ROC) analysis showed that PRISM III at admission could better predict mortality in PICU patients with VAP than PRISM III at the day of VAP episode. (Figure 1). Abstract 811 Figure 1 The area under the curve was found 0.85 (asymptotic 95%CI 0.59 to 1, P<0.01) for PRISM III at admission and 0.72 (95%CI 0.48 to 0.95, P=0,081) for PRISM III at VAP episode. Conclusions PRISM III at admission could better predict mortality in PICU patients with VAP than PRISM III at the day of VAP episode suggesting that VAP may not independently affect mortality.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</pub><doi>10.1136/archdischild-2012-302724.0811</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0003-9888 |
| ispartof | Archives of disease in childhood, 2012-10, Vol.97 (Suppl 2), p.A233-A233 |
| issn | 0003-9888 1468-2044 |
| language | eng |
| recordid | cdi_proquest_journals_1828858739 |
| source | BMJ Journals - NESLi2 |
| subjects | Attrition (Research Studies) Mortality Patients |
| title | 811 Usefullness of the Prism III Score to Predict Outcome in Critically ill Children with VAP |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T03%3A39%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=811%20Usefullness%20of%20the%20Prism%20III%20Score%20to%20Predict%20Outcome%20in%20Critically%20ill%20Children%20with%20VAP&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Stabouli,%20S&rft.date=2012-10&rft.volume=97&rft.issue=Suppl%202&rft.spage=A233&rft.epage=A233&rft.pages=A233-A233&rft.issn=0003-9888&rft.eissn=1468-2044&rft.coden=ADCHAK&rft_id=info:doi/10.1136/archdischild-2012-302724.0811&rft_dat=%3Cproquest_cross%3E4214746631%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1828858739&rft_id=info:pmid/&rfr_iscdi=true |